Gilead to Boost Stake in Belgian Biotech Galapagos as Part of $5.1 Billion Deal - The Wall Street Journal

Gilead to Boost Stake in Belgian Biotech Galapagos as Part of $5.1 Billion Deal  The Wall Street Journal

Gilead Sciences will pay $5.1 billion to lift its stake in Galapagos NV and gain rights outside Europe to the Belgian biotechnology company's treatments in ...

View full coverage on Google News

from Top stories - Google News July 15, 2019 at 01:22AM

Comments

Popular posts from this blog

Jared Leto Was Responsible for the "We Live in a Society" Line in the 'Zack Snyder's Justice League' Trailer - /FILM

How to keep Amazon, Apple, and Google from listening to your Alexa, Siri, and Assistant recordings - TechHive

Exclusive: IAEA found uranium traces at Iran 'atomic warehouse' - diplomats - Reuters